Skip to main content
TRDA
NASDAQ Life Sciences

Safety Committee Clears 15 mg/kg Dose, Entrada Advances DMD Study to Cohort 3

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$4.96
Mkt Cap
$194.186M
52W Low
$4.109
52W High
$16.45
52W Position info
21% above low
Off High info
70% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

TRDA sits 21% above its 52-week low of $4.109.

Summary

An independent safety Data Monitoring Committee reviewed all safety and PK data from the eight patients in Cohort 2 of ELEVATE-45-201 and cleared Entrada to start Cohort 3 at 15 mg/kg, up from 10 mg/kg in Cohort 2 and 5 mg/kg in Cohort 1. That is a dose-escalation green light for ENTR-601-45 in exon 45-skipping Duchenne, and it keeps the program on its planned path after the positive Cohort 1 topline data reported October 14. Cohort 2 enrollment is now complete, with data expected in the first half of 2027 and Cohort 3 to follow. The company is funding operations into Q4 2027 on $193.0 million in cash, so this readout is the next real value inflection rather than a financing risk. Higher dose and exposure is where management expects meaningfully higher dystrophin production, so the Cohort 2 data in H1 2027 is the number that matters.

At the time of this announcement, TRDA was trading at $4.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $194.2M. The 52-week trading range was $4.11 to $16.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

TRDA - Latest Insights

TRDA
Nov 05, 2026, 3:28 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.59
Real-time Price: $4.96 info
Change: +$0.370 (+8%) info
Market Cap: $194.186M info
TRDA
Oct 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.03
Real-time Price: $4.96 info
Change: -$0.070 (-1%) info
Market Cap: $194.186M info
TRDA
Aug 05, 2026, 7:11 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.96 info
Change: -$2.29 (-32%) info
Market Cap: $194.186M info
TRDA
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $4.96 info
Change: -$2.29 (-32%) info
Market Cap: $194.186M info
TRDA
Jun 10, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.80
Real-time Price: $4.96 info
Change: -$0.840 (-14%) info
Market Cap: $194.186M info